The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan–Deficient Muscular Dystrophy-Reference-Cited by-同舟云学术

The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan–Deficient Muscular Dystrophy

Published:2019-02 Issue:2 Volume:189 Page:354-369
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Gazzerro Elisabetta,Baratto Serena,Assereto Stefania,Baldassari Simona,Panicucci Chiara,Raffaghello Lizzia,Scudieri Paolo^ORCID,De Battista Davide,Fiorillo Chiara^ORCID,Volpi Stefano^ORCID,Chaabane Linda,Malnati Mauro,Messina Graziella,Bruzzone Santina^ORCID,Traggiai Elisabetta,Grassi Fabio,Minetti Carlo,Bruno Claudio

Funder

Fondazione Telethon

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference56 articles.

1. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population;Vainzof;J Neurol Sci,1999

2. The clinical spectrum of sarcoglycanopathies;Angelini;Neurology,1999

3. Sarcoglycanopathies;Kirschner;Handb Clin Neurol,2011

4. Inside, outside, upside down: damage−associated molecular−pattern molecules (DAMPs) and redox;Rubartelli;Trends Immunol,2007

5. Adenosine 5'−triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation;Bours;Pharmacol Ther,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced therapeutic approaches in sarcoglycanopathies;Current Opinion in Pharmacology;2024-06

2. Fluoxetine restrains allergic inflammation by targeting an FcɛRI-ATP positive feedback loop in mast cells;Science Signaling;2023-09-12

3. The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies;International Journal of Molecular Sciences;2023-05-29

4. The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies;Current Opinion in Pharmacology;2023-04

5. Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopathies;Laboratory Investigation;2023-03